Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Northcote

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Molecules (Basel, Switzerland)|August 7, 2021
Natural Products from Tongan Marine OrganismsTaitusi Taufa, Ramesh Subramani, Peter T Northcote, et al.
Natural Product Reports|March 31, 2006
Spongian diterpenoids from marine spongesRobert A Keyzers, Peter T Northcote, Michael T Davies-Coleman
Investigational New Drugs|March 31, 2015
Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside AAriane Chan, A Jonathan Singh, Peter T Northcote, et al.
Investigational New Drugs|May 9, 2016
Peloruside A, a microtubule-stabilizing agent, induces aneuploidy in ovarian cancer cellsAriane Chan, A Jonathan Singh, Peter T Northcote, et al.
Investigational New Drugs|February 20, 2010
Peloruside A inhibits microtubule dynamics in a breast cancer cell line MCF7Ariane Chan, Peter M Andreae, Peter T Northcote, et al.
The Journal of Organic Chemistry|May 31, 2014
13C NMR analysis of 3,6-dihydro-2H-pyrans: assignment of remote stereochemistry using axial shielding effectsMark J Bartlett, Peter T Northcote, Matthias Lein, et al.
Molecular Pharmaceutics|April 3, 2007
Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell linesAnja Wilmes, Kelly Bargh, Colleen Kelly, et al.
Current Cancer Drug Targets|November 20, 2013
Resistance to peloruside A and laulimalide: functional significance of acquired βI-tubulin mutations at sites important for drug-tubulin bindingArun Kanakkanthara, Jonathan Eras, Peter T Northcote, et al.
Immunology and Cell Biology|September 25, 2013
Microtubule-stabilizing agents delay the onset of EAE through inhibition of migrationDavid O'Sullivan, John H Miller, Peter T Northcote, et al.
Investigational New Drugs|July 23, 2017
Induction of accelerated senescence by the microtubule-stabilizing agent peloruside AAriane Chan, Connie Gilfillan, Nikki Templeton, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Molecules (Basel, Switzerland)|August 7, 2021
Natural Products from Tongan Marine OrganismsTaitusi Taufa, Ramesh Subramani, Peter T Northcote, et al.
Natural Product Reports|March 31, 2006
Spongian diterpenoids from marine spongesRobert A Keyzers, Peter T Northcote, Michael T Davies-Coleman
Investigational New Drugs|March 31, 2015
Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside AAriane Chan, A Jonathan Singh, Peter T Northcote, et al.
Investigational New Drugs|May 9, 2016
Peloruside A, a microtubule-stabilizing agent, induces aneuploidy in ovarian cancer cellsAriane Chan, A Jonathan Singh, Peter T Northcote, et al.
Investigational New Drugs|February 20, 2010
Peloruside A inhibits microtubule dynamics in a breast cancer cell line MCF7Ariane Chan, Peter M Andreae, Peter T Northcote, et al.
The Journal of Organic Chemistry|May 31, 2014
13C NMR analysis of 3,6-dihydro-2H-pyrans: assignment of remote stereochemistry using axial shielding effectsMark J Bartlett, Peter T Northcote, Matthias Lein, et al.
Molecular Pharmaceutics|April 3, 2007
Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell linesAnja Wilmes, Kelly Bargh, Colleen Kelly, et al.
Current Cancer Drug Targets|November 20, 2013
Resistance to peloruside A and laulimalide: functional significance of acquired βI-tubulin mutations at sites important for drug-tubulin bindingArun Kanakkanthara, Jonathan Eras, Peter T Northcote, et al.
Immunology and Cell Biology|September 25, 2013
Microtubule-stabilizing agents delay the onset of EAE through inhibition of migrationDavid O'Sullivan, John H Miller, Peter T Northcote, et al.
Investigational New Drugs|July 23, 2017
Induction of accelerated senescence by the microtubule-stabilizing agent peloruside AAriane Chan, Connie Gilfillan, Nikki Templeton, et al.
Pageof 7